Interchangeability & Biosimilars Data

The introduction of biosimilar drugs to the market brings new challenges for grouping and reporting on these products and determining if they are rated Interchangeable or Biosimilar. We provide data and identifiers to help prepare you for the growth of biosimilars.

Why do healthcare companies prefer Medi-Span?